EXHIBIT 32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS
ADOPTED PURSUANT TO SECTION 906 OF
THE
SARBANES-OXLEY ACT OF 2002
The
certification set forth below is hereby made solely for the purpose of
satisfying the requirements of Section 906 of the Sarbanes-Oxley Act of 2002 and
may not be relied upon or used for any other purposes.
In
connection with the Quarterly Report of Access Pharmaceuticals, Inc. (the
“Company”) on Form 10-Q for the period ended September 30, 2008, as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), I,
Jeffrey B. Davis, Chief Executive Officer certify pursuant to 18 U.S.C.
1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002, that
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934 and (2) the information contained in the
Report fairly presents, in all material respects, the financial condition and
results of operations of the Company.
A signed
original of this written statement required by Section 906 or other document
authenticating, acknowledging or otherwise adopting the signature that appears
in typed form within the electronic version of this written statement required
by Section 906 has been provided to the Company and will be retained by the
Company and furnished to the Securities and Exchange Commission or its staff
upon request.
Signed at
the City of Dallas, in the State of Texas, this 14th day of November,
2008.
/s/ Jeffrey B.
Davis
Jeffrey
B. Davis
Chief
Executive Officer